相关实验视频
Updated: Jun 24, 2025

09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
15.5K
在TEDDY研究中,青春期发育对自身抗体的出现和1型糖尿病的进展的影响
Katharina Warncke1,2, Roy Tamura3, Desmond A Schatz4
1TUM School of Medicine, Department of Pediatrics, Technical University of Munich, 81675 Munich, Germany.
Journal of the Endocrine Society
|June 13, 2024
概括
在青春期快速增加体重会增加儿童自身免疫的风险. 青春期本身并没有显著影响1型糖尿病或自身抗体的发病.
科学领域:
- 儿科 儿科 儿科
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 1型糖尿病的发病率在童年和青春期达到顶峰.
- 了解青春期发育和1型糖尿病之间的相互作用至关重要.
研究的目的:
- 调查青春期,小岛自身免疫和1型糖尿病进展之间的潜在关系.
- 评估青春期进展,生长和代谢因素对1型糖尿病发展的影响.
主要方法:
- 前性队列研究 (年轻人糖尿病的环境决定因素 - TEDDY研究).
- 使用坦纳阶段评估青春期.
- 使用Cox比例危险比率,分析青春期因素,胰岛素抵抗 (HOMA-IR),小岛自身免疫和1型糖尿病之间的关联.
主要成果:
- 青春期儿童 (坦纳阶段≥2) 与青春期前儿童相比,发生自身免疫的风险较低 (HR 0.65).
- 增加的BMI Z-score与发生胰岛素自身抗体的风险更高有关 (HR 2.88).
- 在患有多个自身抗体的儿童中,HOMA-IR或青春期进展率与1型糖尿病之间没有发现显著的关联.
结论:
- 青春期快速增加体重与小岛自身免疫的发展有关.
- 青春期本身并没有显著影响自身抗体或1型糖尿病的出现.
- 需要进一步的研究来阐明连接青春期和1型糖尿病的潜在机制.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
522
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
522
Insulin: Dosing Regimen and Adverse Effects
165
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
165
Psychoneuroimmunology: Diabetes and Cancer
27
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
27
Signs of Puberty
318
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
318

